Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Mustelin

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
European Journal of Biochemistry|February 1, 1996
Inhibition of phosphatidylinositol 3-kinase blocks T cell antigen receptor/CD3-induced activation of the mitogen-activated kinase Erk2M Von Willebrand, T Jascur, N Bonnefoy-Bérard, et al.
European Cytokine Network|July 21, 2000
Lck is involved in interleukin-2 induced proliferation but not cell survival in human T cells through a MAP kinase-independent pathwayJ Brockdorff, M Nielsen, K Kaltoft, et al.
European Journal of Immunology|May 1, 1992
Regulation of the p59fyn protein tyrosine kinase by the CD45 phosphotyrosine phosphataseT Mustelin, T Pessa-Morikawa, M Autero, et al.
Cellular Signalling|October 26, 1999
The next wave: protein tyrosine phosphatases enter T cell antigen receptor signallingT Mustelin, J Brockdorff, L Rudbeck, et al.
Frontiers in Bioscience : a Journal and Virtual Library|January 10, 2002
Protein tyrosine phosphatasesT Mustelin, G S Feng, N Bottini, et al.
European Journal of Immunology|April 1, 1995
Regulation of the p70zap tyrosine protein kinase in T cells by the CD45 phosphotyrosine phosphataseT Mustelin, S Williams, P Tailor, et al.
Leukemia|August 1, 1997
Diminished TCR signaling in cutaneous T cell lymphoma is associated with decreased activities of Zap70, Syk and membrane-associated CskM C Fargnoli, R L Edelson, C L Berger, et al.
Molecular Immunology|December 1, 1994
Induction of hyperphosphorylation and activation of the p56lck protein tyrosine kinase by phenylarsine oxide, a phosphotyrosine phosphatase inhibitorC Oetken, M von Willebrand, A Marie-Cardine, et al.
Oncogene|June 1, 1994
TCR/CD3-triggering causes increased activity of the p50csk tyrosine kinase and engagement of its SH2 domainC Oetken, C Couture, M Bergman, et al.
The British Journal of Dermatology|October 26, 2016
The complex biology and contribution of Staphylococcus aureus in atopic dermatitis, current and future therapiesL Hepburn, D J Hijnen, B R Sellman, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
European Journal of Biochemistry|February 1, 1996
Inhibition of phosphatidylinositol 3-kinase blocks T cell antigen receptor/CD3-induced activation of the mitogen-activated kinase Erk2M Von Willebrand, T Jascur, N Bonnefoy-Bérard, et al.
European Cytokine Network|July 21, 2000
Lck is involved in interleukin-2 induced proliferation but not cell survival in human T cells through a MAP kinase-independent pathwayJ Brockdorff, M Nielsen, K Kaltoft, et al.
European Journal of Immunology|May 1, 1992
Regulation of the p59fyn protein tyrosine kinase by the CD45 phosphotyrosine phosphataseT Mustelin, T Pessa-Morikawa, M Autero, et al.
Cellular Signalling|October 26, 1999
The next wave: protein tyrosine phosphatases enter T cell antigen receptor signallingT Mustelin, J Brockdorff, L Rudbeck, et al.
Frontiers in Bioscience : a Journal and Virtual Library|January 10, 2002
Protein tyrosine phosphatasesT Mustelin, G S Feng, N Bottini, et al.
European Journal of Immunology|April 1, 1995
Regulation of the p70zap tyrosine protein kinase in T cells by the CD45 phosphotyrosine phosphataseT Mustelin, S Williams, P Tailor, et al.
Leukemia|August 1, 1997
Diminished TCR signaling in cutaneous T cell lymphoma is associated with decreased activities of Zap70, Syk and membrane-associated CskM C Fargnoli, R L Edelson, C L Berger, et al.
Molecular Immunology|December 1, 1994
Induction of hyperphosphorylation and activation of the p56lck protein tyrosine kinase by phenylarsine oxide, a phosphotyrosine phosphatase inhibitorC Oetken, M von Willebrand, A Marie-Cardine, et al.
Oncogene|June 1, 1994
TCR/CD3-triggering causes increased activity of the p50csk tyrosine kinase and engagement of its SH2 domainC Oetken, C Couture, M Bergman, et al.
The British Journal of Dermatology|October 26, 2016
The complex biology and contribution of Staphylococcus aureus in atopic dermatitis, current and future therapiesL Hepburn, D J Hijnen, B R Sellman, et al.
Pageof 8